Redox Limited · ASX:RDX
Redox — Shareholder Meeting (October 2024)
24 slides from Redox's shareholder meeting presentation, Oct 16, 2024
Slide 1: 2024 Annual General Meeting
2024 ANNUAL GENERAL MEETING 16 October 2024 REDOX LIMITED (RDX.ASX) 1
Slide 2: Annual General Meeting Agenda
Annual General Meeting Agenda 1 Chair’s Introduction 2 CEO’s Presentation 3 Formal Business of Meeting 4 Q&A 2
Slide 3: Chair's Introduction
Chair’s Introduction Ian Campbell Non-Executive Chair 3
Slide 4: CEO's Address
CEO’s Address Raimond Coneliano Chief Executive Officer & Managing Director 4
Slide 5: Leading distributor of chemicals, ingredients and raw materials
Leading distributor of chemicals, ingredients and raw materials Primary focus organic Extensive and growing growth complimented customer, supplier by acquisitions & 7,000+ 5,000+ and product base geographic expansion ACTIVE CUSTOMERS SKU’S 100+ 1,000+ STOCK LOCATIONS ACTIVE SUPPLIERS Largest 30-year
Slide 6: Diverse client, industry, product and supplier base
Diverse client, industry, product and supplier base Sales by Country FY24 • Largest customer represents ~1.8% of FY24 sales • Top 10 customers represent ~14.1% of FY24 sales • Largest individual supplier accounted for ~3.1% of FY24 sales • Broad geographical supply base that reduces supply risks • S
Slide 7: Environmental, Social & Governance
Environmental, Social & Governance Redox aims to be a good corporate citizen embracing positive societal and industry engagement, responsible operation and practical initiatives Redox is committed to ethical sourcing, seeks to adhere to the highest ethical standards 7
Slide 8: Group Strategy
GROUP STRATEGY Raimond Coneliano CEO and Managing Director 8
Slide 9: Redox continues to build its platform
Redox continues to build its platform Organic Growth • Volume growth well above historical average in Q1 FY25 • Entity established in Canada in Q1 FY25 to facilitate further expansion in North America • New Sunscreen Active (UV-A absorber) launched in Q1 FY25 with almost $500K sales already Inorgani
Slide 10: FY24 Results Summary
FY24 Results Summary Raimond Coneliano CEO and Managing Director 10
Slide 11: 2024 Highlights
2024 Highlights $94.8m 23.4% 12.2% $115.9m Underlying NPATFX Gross Profit Margin Underlying EBITDAFX Margin Cash Flow from operations 11.4% growth vs PCP 2.6 ppts above PCP 0.8 ppts above PCP (Net Cash position $177m) 11.8% 19.1% 6.5cps 30.8% Proforma Basic Earnings Per Underlying after tax Return O
Slide 12: Profit & Loss overview
Profit & Loss overview FY24 FY23 Change 1.5% Revenue $m 1,137 $m 1,258 -9.6% % Increase in Gross Profit vs PCP due to disciplined Gross profit 266 262 1.5% margin management Gross margin 23.4% 20.8% 2.6ppts 12.2% Underlying EBITDAFX 1 Underlying EBITDAFX 1 margin 139 12.2% 143 11.4% -2.9% 0.8ppts EB
Slide 13: Outlook
Outlook During FY25 Redox will continue to expand our geographic footprint in North America, bolster our product portfolio, increase our share of wallet and grow our client base We remain focused on driving organic revenue growth and anticipate strong volume growth at or above historical average in
Slide 14: Formal Business of Meeting
Formal Business of Meeting 14
Slide 15: How to vote
How to vote • When the poll is open, select the vote icon at the top of the screen • To vote, select either For, Against or Abstain • You will see a vote confirmation • To change or cancel your vote “click here to change your vote” at any time until the poll is closed 15
Slide 16: How to ask a question
How to ask a question • To ask a written question select the Q&A icon • Select the topic your question relates to from the drop-down list • Type your question in the text box and press the send button • To ask a verbal question follow the instructions below the broadcast window 16
Slide 17: Items of Business
Items of Business Item 1 – Financial Report Item 2 – Adoption of Remuneration Report Item 3 – Re-election of Director Item 4 – Grant of Performance Rights Item 4.1 – Raimond Coneliano Item 4.2 – Renato Coneliano Item 4.3 – Richard Coneliano 17
Slide 18: Proxy votes
Proxy votes Item 2 – Adoption of the Remuneration Report For Against Open Abstain Excluded 109,431,369 775,228 102,221 34,665 232,752,371 99.20% 0.70% 0.10% - - 18
Slide 19: Proxy votes
Proxy votes Item 3 – Re-election of Director – Ian Campbell For Against Open Abstain Excluded 294,297,147 27,824,378 2,677,083 16,800,895 0 90.61% 8.57% 0.82% - - 19
Slide 20: Proxy votes
Proxy votes Item 4 - Grant of Performance Rights to Executive Directors Item 4.1 Raimond Coneliano, CEO & Managing Director For Against Open Abstain Excluded 106,461,987 3,747,287 102,221 31,988 232,752,371 96.50% 3.40% 0.10% - - Item 4.2 Renato Coneliano, Marketing Director (Executive Director) For
Slide 21: Complete Voting
Complete Voting 21
Slide 22: Redox
REDOX 22
Slide 23: Disclaimer
Disclaimer Important notices This Presentation has been prepared by Redox Limited (ABN 92 000 762 345) (“RDX” or “Company”). Summary information This Presentation contains summary information about RDX and its activities current as at 30 June 2024. The information in the Presentation is of a general
Slide 24: Redox Global Redox Tweet Redox_global
Re d o xG lo b a l Re d o xTw e e t Re d o x Re d o x_g lo b a l Lim ite d 24